CN103845374A - Whitening and telangiectasis removing drug - Google Patents
Whitening and telangiectasis removing drug Download PDFInfo
- Publication number
- CN103845374A CN103845374A CN201210495913.6A CN201210495913A CN103845374A CN 103845374 A CN103845374 A CN 103845374A CN 201210495913 A CN201210495913 A CN 201210495913A CN 103845374 A CN103845374 A CN 103845374A
- Authority
- CN
- China
- Prior art keywords
- whitening
- parts
- red blood
- skin
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention provides a whitening and telangiectasis removing drug, which comprises, by weight, 25-44 parts of salvianolic acid B, 11-24 parts of proanthocyanidins, 4-9 parts of vitamin P, and 10-15 parts of angelica. The whitening and telangiectasis removing drug has effects of skin immunity enhancing, telangiectasis removing, whitening, blood circulation activating, blood stasis dissipating, microcirculation improving, free radical scavenging and the like, wherein the salvianolic acid B has a strong anti-oxidation effect so as to provide significant effects for skin improving and skin premature aging delaying, the proanthocyanidin is the efficient antioxidant and the strong free radical scavenger, has strong in vivo activity and anti-free radical oxidation, and has effects of immunity enhancing, good whitening and sleep improving, and the proanthocyanidins and the vitamin P are matchedly taken so as to increase the proanthocyanidin absorption rate and the proanthocyanidin utilization rate.
Description
Technical field
The present invention relates to a kind of medicine, relate in particular to a kind of for whitening and the medicine that removes red blood streak.
Background technology
Red blood streak is formed by various impairment factor effects mostly.The epidermal area of skin does not have blood capillary, and the cytotrophy of epidermal area is mainly derived from that the 3rd layer of spinous layer of our skin epidermis provide, impaired when acantholysis cell, self supplies with nutritional capacity and declines.Self possesses repair ability skin, and at this moment independently upwards expansion of the blood capillary of skin corium, helps acantholysis cell that nutrition is provided, thereby form red blood streak.It is heavier that the cytoclasis of epidermal area is more serious, the debatable time is longer, blood capillary proliferation is divided a word with a hyphen at the end of a line, and red blood streak is just more serious.As skin damage 30 ℅, it is the red blood streak that is point-like; Skin damage 50 ℅ are the red blood streak that are wire; Skin damage 70 ℅ are the red blood streak that are netted; Skin damage 90 ℅ are red blood streak in the form of sheets.
In addition work more tired, skin is also more tired.Even if there is on the face " good complexion ", be also because red blood streak is haunting.This is that free radical comes into play on a large scale, makes the immunity of skin further reduce because skin cell, under life fatigue and stress, can not get having a rest fully and taking good care of.Therefore,, in order to eliminate red blood streak, promote skin immunity and be very important.
The problems referred to above are the problems that should solve in the prevention to red blood streak and therapeutic process.
Summary of the invention
The object of this invention is to provide and a kind ofly solve and improve the immunity of skin with the medicine that removes red blood streak for whitening, eliminate gradually the problem of red blood streak.
Technical solution of the present invention is:
For whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 25-44 part, procyanidin be 11-24 part, Citrin be 4-9 part, when being classified as 10-15 part.
Further improve and be: described salvianolic acid B is Radix Salviae Miltiorrhizae extract.
Further improve and be: described procyanidin is Semen Vitis viniferae extract.
Further improve and be: described medicine is made electuary, pill or capsule.
The present invention a kind of for whitening with remove the medicine of red blood streak, there is the skin of lifting immunity, go red blood streak, whitening, activating blood circulation to dissipate blood stasis, improve microcirculation, remove the effects such as free radical.Salvianolic acid B has very strong antioxidation, to improving skin, delaying skin is crossed presenility and can be played obvious effect.Salvianolic acid B is Radix Salviae Miltiorrhizae extract.By Radix Salviae Miltiorrhizae is pulverized, put in extraction pot, add 7-8 and doubly measure 0.01mol/L soak with hydrochloric acid after 24 hours, with 12-14 times of water gaging percolation, the solution that percolation extracts is crossed AB-8 type macroporous resin column and is carried out purification, first removes with 0.01mol/L hydrochloric acid eluting the impurity not being adsorbed, then removes the larger impurity of depolarization with 25% ethanol elution, finally 40% ethanol elution concentrating under reduced pressure is reclaimed after ethanol, lyophilizing obtains the salvianolic acid B that purity is greater than 80%.
Procyanidin is Semen Vitis viniferae extract.Procyanidin is very strong free radical scavenger when being high-efficiency antioxidant agent, has very strong activity in vivo and free radical resisting oxidability, can strengthen body immunity, and has good whitening and improve sleep performance.Procyanidin is matched together with Citrin, can increase absorbance and the utilization rate of human body to procyanidin.Citrin adopts Citrus reticulata Blanco extract, to ensure this kind for whitening and to go the medicine of red blood streak as natural component, avoids medicine to produce untoward reaction.
The invention has the beneficial effects as follows: the present invention a kind of for whitening with remove the medicine of red blood streak, can promote skin immunity, go red blood streak, whitening, activating blood circulation to dissipate blood stasis, improve microcirculation, remove the effects such as free radical.Salvianolic acid B has very strong antioxidation, to improving skin, delaying skin is crossed presenility and can be played obvious effect.Procyanidin is very strong free radical scavenger when being high-efficiency antioxidant agent, has very strong activity in vivo and free radical resisting oxidability, can strengthen body immunity, and has good whitening and improve sleep performance.Procyanidin is matched together with Citrin, can increase absorbance and the utilization rate of human body to procyanidin.
Detailed description of the invention
Describe the preferred embodiments of the present invention below in detail.
For whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 25-44 part, procyanidin be 11-24 part, Citrin be 4-9 part, when being classified as 10-15 part.
Embodiment mono-
The present embodiment provide a kind of for whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 35 parts, procyanidin be 18 parts, Citrin be 9 parts, when being classified as 12 parts.
Embodiment bis-
The present embodiment provide a kind of for whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 25 parts, procyanidin be 20 parts, Citrin be 9 parts, when being classified as 15 parts.
Embodiment tri-
The present embodiment provide a kind of for whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 44 parts, procyanidin be 11 parts, Citrin be 4 parts, when being classified as 10 parts.
Embodiment tetra-
The present embodiment provide a kind of for whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 40 parts, procyanidin be 24 parts, Citrin be 9 parts, when being classified as 10 parts.
Embodiment five
The present embodiment provide a kind of for whitening with remove the medicine of red blood streak, comprise that the weight portion of each component and component is: salvianolic acid B be 32 parts, procyanidin be 15 parts, Citrin be 4 parts, when being classified as 14 parts.
Claims (4)
- For whitening with remove the medicine of red blood streak, it is characterized in that, comprise that the weight portion of each component and component is: salvianolic acid B be 25-44 part, procyanidin be 11-24 part, Citrin be 4-9 part, when being classified as 10-15 part.
- 2. as claimed in claim 1 for whitening and the medicine that removes red blood streak, it is characterized in that: described salvianolic acid B is Radix Salviae Miltiorrhizae extract.
- 3. as claimed in claim 1 or 2 for whitening and the medicine that removes red blood streak, it is characterized in that: described procyanidin is Semen Vitis viniferae extract.
- 4. as claimed in claim 1 or 2 for whitening and the medicine that removes red blood streak, it is characterized in that: described medicine is made electuary, pill or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210495913.6A CN103845374A (en) | 2012-11-29 | 2012-11-29 | Whitening and telangiectasis removing drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210495913.6A CN103845374A (en) | 2012-11-29 | 2012-11-29 | Whitening and telangiectasis removing drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103845374A true CN103845374A (en) | 2014-06-11 |
Family
ID=50853778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210495913.6A Pending CN103845374A (en) | 2012-11-29 | 2012-11-29 | Whitening and telangiectasis removing drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103845374A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105596322A (en) * | 2014-11-17 | 2016-05-25 | 兰赫(上海)生物科技有限公司 | Tyrosinase inhibitor and applications thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102198062A (en) * | 2011-05-26 | 2011-09-28 | 成都中医药大学 | Red sage root mask and preparation method thereof |
| WO2012145609A1 (en) * | 2011-04-21 | 2012-10-26 | Sunny Biodiscovery, Inc. | Transoral methods and compositions for wrinkle reduction and cosmetic lip and facial augmentation |
-
2012
- 2012-11-29 CN CN201210495913.6A patent/CN103845374A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012145609A1 (en) * | 2011-04-21 | 2012-10-26 | Sunny Biodiscovery, Inc. | Transoral methods and compositions for wrinkle reduction and cosmetic lip and facial augmentation |
| CN102198062A (en) * | 2011-05-26 | 2011-09-28 | 成都中医药大学 | Red sage root mask and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| NATHY4: "丹酚酸B的作用", 《HTTP://BLOG.TIANYA.CN/POST-4503329-47372531-1.SHTML》 * |
| 加百列: "《如何选择营养素》", 30 June 2009, 中国社会出版社 * |
| 林海等: "养颜胶囊祛斑作用的人体试食研究", 《福建中医学院学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105596322A (en) * | 2014-11-17 | 2016-05-25 | 兰赫(上海)生物科技有限公司 | Tyrosinase inhibitor and applications thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105687041A (en) | Freckle removing and whitening clay mask | |
| CN104224974A (en) | Chen's antihypertensive tea | |
| CN104224670A (en) | Freckle-removing and whitening mask | |
| CN103845374A (en) | Whitening and telangiectasis removing drug | |
| CN103845728A (en) | Spot removing and wrinkle removing drug | |
| CN103584108A (en) | Functional health food for relieving cough and reducing sputum | |
| CN103041191A (en) | Traditional Chinese medicine composition for reducing blood pressure | |
| CN102949615A (en) | Medicine for treating hypertension | |
| CN102934670A (en) | Biscuit containing papaya extracts | |
| CN104055855B (en) | The food therapeutic composition that can lose weight | |
| CN102151294A (en) | Heat-nourishing sedum kamtschaticum and cordyceps militaris wine | |
| CN101708150B (en) | Bath health vinegar and preparation method thereof | |
| CN104642845A (en) | Orange and longan honey | |
| CN103380930A (en) | Bamboo juice, vine tea and fruit juice beverage | |
| CN102343039A (en) | Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like | |
| CN106866833A (en) | Camellia chrysantha polysaccharide with anti-stress effect and preparation method thereof | |
| CN105770120A (en) | Traditional Chinese medicine formula for treating humid eczema dermatitis | |
| CN104988002A (en) | Health wine for lowering lipid and stabilizing blood pressure | |
| CN104971198A (en) | Medicinal liquor | |
| CN103181878B (en) | A kind of whitening cream compositions | |
| CN103536780A (en) | Pawpaw traditional Chinese medicinal preparation | |
| CN109316410A (en) | A kind of antidusting Chinese herbal medicine face cream | |
| CN104055088A (en) | Dietotherapy health care composition for whitening and freckle removal | |
| CN103655733A (en) | Traditional Chinese medicine composition with blood pressure reducing function | |
| CN103393843A (en) | Traditional Chinese medicine composition for reducing blood pressure and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140611 |
|
| RJ01 | Rejection of invention patent application after publication |